229 related articles for article (PubMed ID: 8286777)
21. [Usefulness of sialic acid determination to differentiation between alcohol abuse and alcoholic liver cirrhosis].
Cylwik B; Brodowska D; Chrostek L; Panasiuk A; Szmitkowski M
Pol Merkur Lekarski; 2009 Nov; 27(161):368-71. PubMed ID: 19999798
[TBL] [Abstract][Full Text] [Related]
22. A combination of raised serum AST:ALT ratio and erythrocyte mean cell volume level detects excessive alcohol consumption.
Kawachi I; Robinson GM; Stace NH
N Z Med J; 1990 Apr; 103(887):145-8. PubMed ID: 2342668
[TBL] [Abstract][Full Text] [Related]
23. An overview of serum mitochondrial aspartate aminotransferase (mAST) activity as a marker of chronic alcohol abuse.
Nalpas B; Vassault A; Poupon RE; Pol S; Berthelot P
Alcohol Alcohol Suppl; 1991; 1():455-7. PubMed ID: 1845577
[No Abstract] [Full Text] [Related]
24. Red blood cell status in alcoholic and non-alcoholic liver disease.
Maruyama S; Hirayama C; Yamamoto S; Koda M; Udagawa A; Kadowaki Y; Inoue M; Sagayama A; Umeki K
J Lab Clin Med; 2001 Nov; 138(5):332-7. PubMed ID: 11709657
[TBL] [Abstract][Full Text] [Related]
25. Increased serum tissue polypeptide specific antigen (TPS) in alcoholics: a possible marker of alcoholic hepatitis.
González-Quintela A; Mella C; Pérez LF; Abdulkader I; Caparrini AM; Lojo S
Alcohol Clin Exp Res; 2000 Aug; 24(8):1222-6. PubMed ID: 10968661
[TBL] [Abstract][Full Text] [Related]
26. Ethanol-induced dysfunction of hepatocytes and leukocytes in patients without liver failure.
Gheorghiu M; Bâră C; Păsărică D; Braşoveanu L; Bleotu C; Topârceanu F; Trandafir T; Diaconu CC
Roum Arch Microbiol Immunol; 2004; 63(1-2):5-33. PubMed ID: 16295318
[TBL] [Abstract][Full Text] [Related]
27. Non-invasive monitoring of oxidant stress in alcoholic liver disease.
Pemberton PW; Smith A; Warnes TW
Scand J Gastroenterol; 2005 Sep; 40(9):1102-8. PubMed ID: 16165720
[TBL] [Abstract][Full Text] [Related]
28. Determination of serum carbohydrate-deficient transferrin in the diagnosis of alcoholic liver disease.
Liu YS; Xu GY; Cheng DQ; Li YM
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):265-8. PubMed ID: 15908327
[TBL] [Abstract][Full Text] [Related]
29. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
[TBL] [Abstract][Full Text] [Related]
30. Gastrectomy, lack of gastric first pass metabolism of ethanol and alcoholic liver disease. Results of a multicentre study.
Frezza M; Buda A; Terpin MM; Aricò S; Benvenuti S; Burra P; Casini A; Iaquinto G; Manghisi OG; Pasquale L; Petruzzi J; Salvagnini M; Surrenti E; Tabone M; Zancanella L
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):243-8. PubMed ID: 9646216
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the carbon 13-labeled Ketoisocaproate breath test to assess mitochondrial dysfunction in patients with high alcohol consumption.
Bendtsen P; Hannestad U; Påhlsson P
Alcohol Clin Exp Res; 1998 Nov; 22(8):1792-5. PubMed ID: 9835297
[TBL] [Abstract][Full Text] [Related]
32. Serum leptin levels in alcoholic liver cirrhosis: relationship with gender, nutritional status, liver function and energy metabolism.
Campillo B; Sherman E; Richardet JP; Bories PN
Eur J Clin Nutr; 2001 Nov; 55(11):980-8. PubMed ID: 11641747
[TBL] [Abstract][Full Text] [Related]
33. Relationships among serum iron status markers, chemical and histochemical liver iron content in 117 patients with alcoholic and non-alcoholic hepatic disease.
Milman N; Graudal N; Hegnhøj J; Christoffersen P; Pedersen NS
Hepatogastroenterology; 1994 Feb; 41(1):20-4. PubMed ID: 8175108
[TBL] [Abstract][Full Text] [Related]
34. [Biological diagnosis of the type of liver disease in alcoholic patients with abnormal liver function tests].
Naveau S; Montembault S; Balian A; Giraud V; Aubert A; Abella A; Capron F; Chaput JC
Gastroenterol Clin Biol; 1999 Nov; 23(11):1215-24. PubMed ID: 10617832
[TBL] [Abstract][Full Text] [Related]
35. Increased lipid and protein oxidation and DNA damage in patients with chronic alcoholism.
Mutlu-Türkoğlu U; Doğru-Abbasoğlu S; Aykaç-Toker G; Mirsal H; Beyazyürek M; Uysal M
J Lab Clin Med; 2000 Oct; 136(4):287-91. PubMed ID: 11039849
[TBL] [Abstract][Full Text] [Related]
36. Quality of life and nutritional status in alcohol addicts and patients with chronic liver disease.
Panagaria N; Varma K; Nijhawan S; Mathur A; Rai RR
Trop Gastroenterol; 2007; 28(4):171-5. PubMed ID: 18416348
[TBL] [Abstract][Full Text] [Related]
37. Serum sialic acid as a marker of alcohol consumption: effect of liver disease and heavy drinking.
Romppanen J; Punnonen K; Anttila P; Jakobsson T; Blake J; Niemelä O
Alcohol Clin Exp Res; 2002 Aug; 26(8):1234-8. PubMed ID: 12198399
[TBL] [Abstract][Full Text] [Related]
38. [Activity of beta-hexosaminidase in serum of patients with alcoholic and nonalcoholic liver diseases].
Wehr H; Czartoryska B; Milewski B
Wiad Lek; 1995; 48(1-12):91-5. PubMed ID: 9638214
[TBL] [Abstract][Full Text] [Related]
39. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
40. Serum selenium levels in alcoholic liver disease.
Jabłońska-Kaszewska I; Swiatkowska-Stodulska R; Łukasiak J; Dejneka W; Dorosz A; Dabrowska E; Falkiewicz B
Med Sci Monit; 2003 Aug; 9 Suppl 3():15-8. PubMed ID: 15156604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]